Evidence map›Paper›PMID 33738911›Full record

ArticleJournal of cellular and molecular medicine2021

Lipid metabolism regulator human hydroxysteroid dehydrogenase-like 2 (HSDL2) modulates cervical cancer cell proliferation and metastasis.

Yang Yang, Anna Han, Xinyue Wang, Xianglin Yin, Minghua Cui, Zhenhua Lin

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Mitochondria-related HSDL2 is a potential biomarker in temporal lobe epilepsy by modulating astrocytic lipid metabolism.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yang YangDepartment of Pathology and Cancer Research Center, Yanbian University Medical College, Yanji, China.
Anna HanDepartment of Pathology and Cancer Research Center, Yanbian University Medical College, Yanji, China.
Xinyue WangDepartment of Pathology and Cancer Research Center, Yanbian University Medical College, Yanji, China.ORCID 0000-0002-0754-935X
Xianglin YinDepartment of Pathology and Cancer Research Center, Yanbian University Medical College, Yanji, China.
Minghua CuiDepartment of Pathology and Cancer Research Center, Yanbian University Medical College, Yanji, China.
Zhenhua LinDepartment of Pathology and Cancer Research Center, Yanbian University Medical College, Yanji, China.
Yanbian University of Science and Technology · CN

Funding

National Natural Science Foundation of China 31760313The Funds of Tumen River Scholar Project, Startup Foundation for Docotors, Application Basic of Yanbian University and Doctoral Research Fund of Yanbian UniversityThe Special Funds for Local Science and Technology Development Guided by the Central Committee, basic research progject of Jilin Province 202002021JC
6 · The paper itself

Abstract

Human hydroxysteroid dehydrogenase-like 2 (HSDL2) is a potent regulator in cancers and is also involved in lipid metabolism, but the role of HSDL2 in cervical cancer and whether it regulates the progress of cervical cancer through lipid metabolism remains unclear. In this study, we found that the overexpression of HSDL2 was in relation with cervical cancer progression including lymph nodes metastasis and recurrence. HSDL2 could serve as a novel marker of early diagnosis in cervical cancer. HSDL2 also gave impetus to tumorigenesis by initiating and promoting proliferation, invasion and migration of cervical cancer cells (Hela, C33A and SiHa) through EMT. Interestingly, we also searched that HSDL2 participated in oncogenesis by regulating lipid metabolism. In sum, our results gave the novel insight of HSDL2 functions which could be the potential for being the biomarker of prognosis and new target of therapy.

Indexed as

Cell ProliferationGene Expression Regulation, NeoplasticLipid MetabolismAdultAgedApoptosisBiomarkers, TumorCell MovementFemaleHumansHydroxysteroid DehydrogenasesMiddle AgedNeoplasm MetastasisPrognosisSurvival RateTumor Cells, CulturedBiomarkers, TumorHSDL2 protein, humanHydroxysteroid Dehydrogenasescervical cancerEMTHSDL2lipid metabolismprognosis

Identifiers

PMID33738911
PMCPMC8107089
OpenAlexW3137983008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.